Additionally, it serves as a transcriptional control mechanism and functions as a competing endogenous RNA (ceRNA) that interacts with microRNAs and modulates their activity.[12–14] Dysregulation of MALAT1 has been associated with several diseases, including cancer,[12] cardiovascular disorders,[15] and more recently, ocular pathologies like retinopathy.[9] Although retinopathy and MALAT1 initially appear to be distinct areas of research, emerging evidence suggests a potential connection between them. Here, MALAT1 is linked to cardiovascular disorder.